Lesion detection by [(89)Zr]Zr-DFO-girentuximab and [(18)F]FDG-PET/CT in patients with newly diagnosed metastatic renal cell carcinoma

PURPOSE: The main objective of this preliminary analysis of the IMaging PAtients for Cancer drug selecTion (IMPACT)-renal cell cancer (RCC) study is to evaluate the lesion detection of baseline contrast-enhanced CT, [(89)Zr]Zr-DFO-girentuximab-PET/CT and [(18)F]FDG-PET/CT in detecting ccRCC lesions...

Descripción completa

Detalles Bibliográficos
Autores principales: Verhoeff, Sarah R., van Es, Suzanne C., Boon, Eline, van Helden, Erik, Angus, Lindsay, Elias, Sjoerd G., Oosting, Sjoukje F., Aarntzen, Erik H., Brouwers, Adrienne H., Kwee, Thomas C., Heskamp, Sandra, Hoekstra, Otto S., Verheul, Henk, van der Veldt, Astrid A. M., de Vries, Elisabeth G. E., Boerman, Otto C., van der Graaf, Winette T. A., Oyen, Wim J. G., van Herpen, Carla M. L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2019
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6647180/
https://www.ncbi.nlm.nih.gov/pubmed/31172212
http://dx.doi.org/10.1007/s00259-019-04358-9

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6647180/
https://www.ncbi.nlm.nih.gov/pubmed/31172212
http://dx.doi.org/10.1007/s00259-019-04358-9

Ejemplares similares